| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |